Dr. Mark Tarnopolsky is a Professor and Division Head of Neuromuscular and Neurometabolic Disorders in the Department of Pediatrics at McMaster University. He completed a Ph.D. in Cell Biology and Metabolism in 2001, followed by five years of training in Internal Medicine, Neurology and Physical Medicine and Rehabilitation at McMaster University and the University of Rochester in New York. After accepting a faculty position at McMaster University in 1996, he has focused his practice predominately in the area of mitochondrial disease, muscle disorders (muscular dystrophy) and other neurometabolic disorders. He also holds a Chair in Neuromuscular Disorders from McMaster Children's Hospital/Hamilton Health Sciences Foundation since 2010.
In addition to a very busy clinical practice in neuromuscular and neurometabolic disease, his laboratory publishes approximately 25 papers per year looking at mitochondrial and muscle function in patients, aging and in animal models of pediatric and adult neuromuscular and neurometabolic diseases. His clinical research focuses predominately on therapies for mitochondrial cytopathies; however, his group is also involved in clinical trials in Duchenne muscular dystrophy, Friedreich's ataxia, and Pompe disease.